Maintenance Therapy Using Lenalidomide in Myeloma

Summary

Maintenance Therapy Using Lenalidomide in Myeloma is a clinical trial^[1].

Key Facts

• Maintenance Therapy Using Lenalidomide in Myeloma is in the country of Belgium^[2].
• Maintenance Therapy Using Lenalidomide in Myeloma is in the country of France^[3].
• Maintenance Therapy Using Lenalidomide in Myeloma is in the country of Switzerland^[4].
• Maintenance Therapy Using Lenalidomide in Myeloma's instance of is recorded as clinical trial^[5].
• Maintenance Therapy Using Lenalidomide in Myeloma's start time is recorded as +2006-06-30T00:00:00Z^[6].
• Maintenance Therapy Using Lenalidomide in Myeloma's end time is recorded as +2017-09-30T00:00:00Z^[7].
• Maintenance Therapy Using Lenalidomide in Myeloma's main subject is recorded as multiple myeloma^[8].
• Maintenance Therapy Using Lenalidomide in Myeloma's number of participants is recorded as {'unit': '1', 'amount': '+614'}^[9].
• Maintenance Therapy Using Lenalidomide in Myeloma's title is recorded as Relevance of Maintenance Therapy Using Lenalidomide (Revimid®) After Autologous Stem Cell Transplantation Patients Under the Age Of 65. (Open, Randomised, Multi-centric Trial Versus Placebo).^[10].
• Maintenance Therapy Using Lenalidomide in Myeloma's short name is recorded as IFM2005-02^[11].
• Maintenance Therapy Using Lenalidomide in Myeloma's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[12].
• Maintenance Therapy Using Lenalidomide in Myeloma's ClinicalTrials.gov ID is recorded as NCT00430365^[13].
• Maintenance Therapy Using Lenalidomide in Myeloma's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[14].
• Maintenance Therapy Using Lenalidomide in Myeloma's research intervention is recorded as (RS)-lenalidomide^[15].
• Maintenance Therapy Using Lenalidomide in Myeloma's clinical trial phase is recorded as phase III clinical trial^[16].
• Maintenance Therapy Using Lenalidomide in Myeloma's research site is recorded as ZNA Middelheim Hospital^[17].
• Maintenance Therapy Using Lenalidomide in Myeloma's research site is recorded as Antwerp University Hospital^[18].
• Maintenance Therapy Using Lenalidomide in Myeloma's research site is recorded as Hôpital Lyon Sud^[19].
• Maintenance Therapy Using Lenalidomide in Myeloma's research site is recorded as Centre Henri-Becquerel^[20].
• Maintenance Therapy Using Lenalidomide in Myeloma's study type is recorded as interventional study^[21].